These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3112649

  • 1. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
    O'Brien AA, McParland C, Keogh JA.
    Nephrol Dial Transplant; 1987; 2(2):117-9. PubMed ID: 3112649
    [Abstract] [Full Text] [Related]

  • 2. [Chronic aluminum poisoning in continuous ambulatory peritoneal dialysis: treatment with deferoxamine].
    Passlick J, Wilhelm M, Busch T, Grabensee B, Ohnesorge FK.
    Dtsch Med Wochenschr; 1989 Feb 17; 114(7):253-7. PubMed ID: 2917487
    [Abstract] [Full Text] [Related]

  • 3. Changes of metal concentrations in blood and peritoneal dialysate during long-term desferrioxamine B therapy.
    Romero RA, Salgado O, Elejalde LE, Rodríguez-Iturbe B, Tahán JE.
    Transplant Proc; 1996 Dec 17; 28(6):3385-7. PubMed ID: 8962321
    [No Abstract] [Full Text] [Related]

  • 4. Aluminum and deferoxamine kinetics in CAPD.
    Mactier RA.
    Adv Perit Dial; 1991 Dec 17; 7():26-9. PubMed ID: 1680440
    [Abstract] [Full Text] [Related]

  • 5. Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine.
    Warady BA, Ford DM, Gaston CE, Sedman AB, Huffer WE, Lum GM.
    Pediatrics; 1986 Oct 17; 78(4):651-5. PubMed ID: 3763276
    [Abstract] [Full Text] [Related]

  • 6. [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
    Charhon SA, Chavassieux P, Chapuy MC, Accominotti M, Traeger J, Meunier PJ.
    Presse Med; 1986 Jan 18; 15(2):55-9. PubMed ID: 2935857
    [Abstract] [Full Text] [Related]

  • 7. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D, Simícková J, Kubátko J, Syrovátka P.
    Cas Lek Cesk; 1989 Dec 15; 128(51):1611-4. PubMed ID: 2631999
    [Abstract] [Full Text] [Related]

  • 8. Removal of trace metals by continuous ambulatory peritoneal dialysis after desferrioxamine B chelation therapy.
    Navarro JA, Granadillo VA, Rodríguez-Iturbe B, García R, Salgado O, Romero RA.
    Clin Nephrol; 1991 May 15; 35(5):213-7. PubMed ID: 1855329
    [Abstract] [Full Text] [Related]

  • 9. Haemofiltration or haemodialysis in aluminium elimination?
    Sulkova S, Laurincova Z, Válek A.
    Nephrol Dial Transplant; 1991 May 15; 6 Suppl 3():3-5. PubMed ID: 1775263
    [Abstract] [Full Text] [Related]

  • 10. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS, Hercz G, Miller JH, Shinaberger JH, Nissenson AR, Coburn JW.
    Kidney Int Suppl; 1986 Feb 15; 18():S100-3. PubMed ID: 3457984
    [No Abstract] [Full Text] [Related]

  • 11. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
    Rapoport J, Chaimovitz C, Abulfil A, Mostovlavsky M, Gazit D, Bab I.
    Isr J Med Sci; 1987 Dec 15; 23(12):1242-6. PubMed ID: 3440748
    [Abstract] [Full Text] [Related]

  • 12. [Osteomalacia induced by aluminum in a patient under chronic hemodialysis: successful treatment with desferrioxamine].
    Espinoza O, Gehrung E, Roessler E, Katz E, Pérez A, Delmastro J.
    Rev Med Chil; 1986 Sep 15; 114(9):867-71. PubMed ID: 3575972
    [No Abstract] [Full Text] [Related]

  • 13. Successful treatment of aluminium encephalopathy by intraperitoneal desferrioxamine.
    Payton CD, Junor BJ, Fell GS.
    Lancet; 1984 May 19; 1(8386):1132-3. PubMed ID: 6144870
    [No Abstract] [Full Text] [Related]

  • 14. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE, Johnson CA.
    Clin Pharm; 1985 May 19; 4(4):434-9. PubMed ID: 3899471
    [Abstract] [Full Text] [Related]

  • 15. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
    Mudde AH, Roodvoets AP, Van Groningen K.
    Neth J Med; 1985 May 19; 28(1):6-11. PubMed ID: 3974771
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
    Douthat WG, Acuña Aguerre G, Fernández Martín JL, Mouzo R, Cannata Andía JB.
    Nephrol Dial Transplant; 1994 May 19; 9(10):1431-4. PubMed ID: 7816256
    [Abstract] [Full Text] [Related]

  • 17. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
    Graf H, Stummvoll HK, Meisinger V.
    Proc Eur Dial Transplant Assoc; 1981 May 19; 18():674-80. PubMed ID: 7329995
    [Abstract] [Full Text] [Related]

  • 18. Aluminum removal by peritoneal dialysis: intravenous vs. intraperitoneal deferoxamine.
    Hercz G, Salusky IB, Norris KC, Fine RN, Coburn JW.
    Kidney Int; 1986 Dec 19; 30(6):944-8. PubMed ID: 3820944
    [Abstract] [Full Text] [Related]

  • 19. Deferoxamine for the treatment of hemosiderosis during CAPD.
    Gomez RA, Campbell F, Savory J, Chevalier RL.
    Int J Pediatr Nephrol; 1987 Dec 19; 8(1):21-4. PubMed ID: 3583552
    [Abstract] [Full Text] [Related]

  • 20. Changes in bone histology after treatment with desferrioxamine.
    Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ.
    Kidney Int Suppl; 1986 Feb 19; 18():S108-13. PubMed ID: 3457986
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.